PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.26 +0.04 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

PMV Pharmaceuticals (PMVP) Return on Equity [ROE] (2020 - 2026)

Updated

PMV Pharmaceuticals' Return on Equity [ROE] was -94.34% in Q2 2026, down 40.55 percentage points from -53.79% a year earlier and down 13.02 percentage points from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at PMV Pharmaceuticals came in at -55.37%, down 26.15 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of -31.51 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -29.23% in FY2024 (+0.01 pp), -29.24% in FY2023 (-2.80 pp), -26.44% in FY2022 (-9.11 pp) and -17.33% in FY2021 (+6.54 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q3 2020.
  • Compared with a year earlier, Return on Equity [ROE] has declined for seven straight quarters, with an average year-over-year change of -24.19 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2024 (a gain of 10.20 percentage points); the worst was Q1 2026 (a drop of 45.11 percentage points).
  • Per Business Quant data, PMVP's Return on Equity [ROE] in the three quarters before Q2 2026 was -81.32% (Q1 2026), -68.89% (Q4 2025) and -63.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 PMV Pharmaceuticals 80.80 Mn -307.68 Mn - -138.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -138.06%
Jun 30, 2026 -94.47%
Mar 31, 2026 -81.42%
Dec 31, 2025 -68.94%
Sep 30, 2025 -63.47%
Jun 30, 2025 -53.65%
Mar 31, 2025 -36.09%
Dec 31, 2024 -31.44%
Sep 30, 2024 -24.60%
Jun 30, 2024 -22.83%
Mar 31, 2024 -29.71%
Dec 31, 2023 -29.48%
Sep 30, 2023 -31.57%
Jun 30, 2023 -32.79%
Mar 31, 2023 -30.85%
Dec 31, 2022 -29.05%
Sep 30, 2022 -27.27%
Jun 30, 2022 -24.66%
Mar 31, 2022 -21.76%
Dec 31, 2021 -18.29%
API Access

PMV Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEY